CorMedix Inc. (CRMD) vs 908 Devices Inc. (MASS)

A side-by-side comparison of CorMedix Inc. and 908 Devices Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRMD vs MASS

growth of $100 · dividends reinvested · last 6y
CRMD -9.0% (-1.6%/yr)MASS -73.9% (-20.0%/yr)CRMD compounded faster over this window
050100150200Start $100202120222023202420252026$91$26
CRMD MASS

CRMD vs MASS: by the numbers

  • •CRMD is the larger company ($562M vs $513M market cap).
  • •CRMD is profitable (40.49% net margin) while MASS runs a net loss (-56.68%).
  • •CRMD grew revenue faster over the past five years (352.03% vs 18.92% CAGR).

Metrics side by side

Valuation

MetricCRMDMASS
P/E ratio3.36N/A
Forward P/E14.47N/A
P/S ratio1.228.44
P/B ratio1.224.05
EV / EBITDA1.79N/A
FCF yield44.53%0.09%

Profitability

MetricCRMDMASS
Gross margin82.78%49.79%
Operating margin46.95%-46.01%
Net margin40.49%-56.68%
ROE40.62%-27.20%
ROIC27.87%-18.90%

Growth (annualized)

MetricCRMDMASS
Revenue CAGR (5Y)352.03%18.92%
Total return CAGR (5Y)9.70%-17.66%

Frequently asked

Which has grown faster, CRMD or MASS?
Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus MASS at 18.92%.
Is CRMD or MASS more profitable?
CRMD runs the higher net margin — CRMD at 40.49% versus MASS at -56.68%.
How have CRMD and MASS total returns compared?
Over the past 5 years, CRMD delivered 9.70% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.